Solly Jeremy E, Grant Jon E, Chamberlain Samuel R
Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; Department of Psychiatry, University of Cambridge, UK.
University of Chicago, Department of Psychiatry and Behavioral Neuroscience, Chicago, IL, USA.
Curr Opin Behav Sci. 2022 Jun 11;46:101158. doi: 10.1016/j.cobeha.2022.101158. eCollection 2022 Aug.
Problematic Usage of the Internet (PUI) represents a spectrum of excessive online behaviors and is linked to reduced quality of life and high rates of psychiatric comorbidity, with growing demand for effective treatments. This paper provides a narrative review of pharmacological studies for PUI conducted to date. Most pharmacological treatment trials have focused on bupropion and escitalopram or involved samples with common comorbidities and used current treatments for the relevant comorbid disorders. Overall, there remains a dearth of high-quality evidence, with the current literature lacking control groups, large sample sizes, validated outcome measures, longer term treatment and follow-up periods. The literature cannot at this stage determine evidence-based pharmacological treatments for PUI.
网络使用问题(PUI)表现为一系列过度的在线行为,与生活质量下降和精神疾病共病率高有关,对有效治疗的需求日益增加。本文对迄今为止进行的关于PUI的药理学研究进行了叙述性综述。大多数药物治疗试验都集中在安非他酮和艾司西酞普兰上,或者涉及有常见共病的样本,并使用针对相关共病疾病的现有治疗方法。总体而言,仍然缺乏高质量的证据,目前的文献缺乏对照组、大样本量、经过验证的结局指标、长期治疗和随访期。目前阶段,文献无法确定基于证据的PUI药物治疗方法。